Certain fertility treatments associated with Kawasaki disease risk in children
en-GBde-DEes-ESfr-FR

Certain fertility treatments associated with Kawasaki disease risk in children


Osaka, Japan - A large-scale study in Japan, led by researchers from the University of Osaka and the Osaka Women's and Children's Hospital, has found that certain fertility treatments are associated with an increased risk of Kawasaki disease before age five, although the association differed by treatment type. The findings were published in JAMA Network Open.

Kawasaki disease is a systemic inflammatory disease that primarily affects young children and is a leading cause of acquired heart disease in children. Its exact cause remains unclear.

The research team analyzed data from 101,864 children participating in the Japan Environment and Children’s Study (JECS), a nationwide prospective birth cohort. They examined Kawasaki disease occurring before age 5 among children conceived spontaneously or following ovulation induction, intrauterine insemination (IUI), in vitro fertilization (IVF), or intracytoplasmic sperm injection (ICSI).

During the 5-year follow-up, 1,226 children developed Kawasaki disease. Compared with spontaneous conception, the risk was higher following ovulation induction (adjusted hazard ratio [HR], 1.57), IUI (HR, 1.48), and IVF (HR, 1.53). ICSI showed no clear difference in risk (HR, 0.91).

These patterns remained broadly consistent after accounting for maternal conditions including endometriosis, polycystic ovary syndrome, allergic conditions, and autoimmune disease.

“Kawasaki disease remains an important cause of acquired heart disease in children, yet its causes are still not fully understood,” Ryo Kawasaki said. “Further investigation of the association between fertility treatments and Kawasaki disease may help clarify the mechanisms underlying the disease.”

The results highlight a nuanced relationship between fertility treatments and child health, showing that the association with Kawasaki disease differs by treatment type. The authors emphasize that the findings show associations rather than causation and require confirmation in other populations.
###
The article, “Fertility Treatments and the Risk of Kawasaki Disease Among Offspring,” was published in JAMA Network Open at DOI: https://doi.org/10.1001/jamanetworkopen.2026.28586

About The University of Osaka
The University of Osaka was founded in 1931 as one of the seven imperial universities of Japan and is now one of Japan's leading comprehensive universities with a broad disciplinary spectrum. This strength is coupled with a singular drive for innovation that extends throughout the scientific process, from fundamental research to the creation of applied technology with positive economic impacts. Its commitment to innovation has been recognized in Japan and around the world. Now, The University of Osaka is leveraging its role as a Designated National University Corporation selected by the Ministry of Education, Culture, Sports, Science and Technology to contribute to innovation for human welfare, sustainable development of society, and social transformation.
Website: https://resou.osaka-u.ac.jp/en
Title: Fertility Treatments and the Risk of Kawasaki Disease Among Offspring
Journal: JAMA Network Open
Authors: Sachiko Baba, Kanami Tanigawa, Junji Miyazaki, Kazuko Wada, Michiko Kodama, Ryo Kawasaki, Hiroyasu Iso
DOI: 10.1001/jamanetworkopen.2026.28586
Funded by: Ministry of the Environment
Article publication date: 12-AUG-2026
Related links:
Ryo Kawasaki
https://rd.iai.osaka-u.ac.jp/en/4c89cb09922bae2c.html
Angehängte Dokumente
  • Fig. 1 Hazard Ratios of Kawasaki Disease, by Method of Conception©Original content, No restrictions., Sachiko Baba
Regions: Asia, Japan, North America, United States
Keywords: Health, Medical, People in health research

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Referenzen

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Wir arbeiten eng zusammen mit...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement